Results of the PURPOSE 1 trial indicated that treatment with lenacapavir was superior to Descovy and Truvada.
Phase III Trial Data Demonstrates Efficacy of Lenacapavir in Preventing HIV in Cisgender Women
Results of the PURPOSE 1 trial indicated that treatment with lenacapavir was superior to Descovy and Truvada.